DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

NCT00274118 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetes Mellitus, Type 2

Interventions

DRUG: telmisartan
DRUG: enalapril

Sponsor

Boehringer Ingelheim